A recent systematic review published in the journal Nutrients reveals that extra virgin olive oil (EVOO) not only enhances the flavor of meals but also plays a significant role in protecting heart health. Particularly when incorporated as a key component of the Mediterranean diet, EVOO helps combat heart disease, reduce inflammation, and improve vascular function. Researchers from Italy emphasize that regular consumption of polyphenol-rich EVOO can lower the risk of cardiovascular disease (CVD), with the strongest evidence supporting benefits in patients with existing conditions or high-risk groups.
EVOO’s unique health benefits stem from its rich content of bioactive polyphenols, such as hydroxytyrosol (HYTY) and tyrosol (TY), which have potent antioxidant properties. These compounds effectively reduce oxidative stress and inflammation—two primary drivers of atherosclerosis and cardiovascular disease. In 2012, the European Food Safety Authority approved a health claim stating that consuming 20 grams of olive oil containing at least 5 mg of HYTY helps prevent lipid oxidation in the blood.
The review analyzed multiple clinical trials showing that EVOO improves endothelial function, increases nitric oxide availability, and lowers inflammatory markers like C-reactive protein (CRP) and interleukin-6 (IL-6). It also favorably modifies blood lipid profiles by reducing oxidized low-density lipoprotein (LDL) cholesterol and raising protective high-density lipoprotein (HDL) levels. These changes correlate with lower systolic blood pressure and improved ankle-brachial index (ABI), indicating better circulation.
However, the benefits were primarily observed with high-polyphenol EVOO and mainly in populations at high cardiovascular risk or with existing disease, leaving effects on healthy individuals less certain. Limitations such as small sample sizes, varied olive oil formulations, and heterogeneous study populations constrain broader application of the findings. The authors call for larger, multi-center clinical trials to strengthen the evidence.
Notably, a seven-year Spanish study found that a Mediterranean diet rich in EVOO was more effective than a low-fat diet in reducing cardiovascular events. Research from Australia showed that polyphenol-rich EVOO significantly lowered systolic blood pressure and oxidized LDL levels, with greater benefits in individuals with abdominal obesity or high inflammation. EVOO also improved endothelial function in prediabetic patients, suggesting its potential to prevent cardiovascular complications.
At the molecular level, EVOO modulates gene expression related to inflammation and heart health. Certain metabolites associated with EVOO consumption correlate negatively with cardiovascular risk but show no significant link to type 2 diabetes. Variability in olive oil composition and polyphenol concentration complicates comparisons across studies, highlighting the need for standardized EVOO products in future research.
In summary, extra virgin olive oil—with its high monounsaturated fat content and antioxidant polyphenols—offers an effective food-based strategy for cardiovascular prevention, especially in high-risk groups. As a cornerstone of the Mediterranean diet, it helps regulate inflammation and oxidative stress, improves lipid profiles and blood pressure, enhances vascular function, and protects against atherosclerosis and coronary heart disease.
Experts recommend daily intake of 20–30 grams of standardized, high-polyphenol EVOO alongside a healthy lifestyle to reduce cardiovascular risk. Meanwhile, researchers advocate for more rigorous clinical trials and standardized product formulations and consumption guidelines to fully harness EVOO’s cardioprotective potential.
As an ancient yet modern superfood, extra virgin olive oil is increasingly recognized as a powerful ally for heart health, particularly for those seeking dietary prevention of cardiovascular disease.
Related Topics
